Stock Performance and Dividends
Price on June 17, 2015:
On June 17, 2015, Eli Lilly’s stock price was approximately $80 per share (historical data may vary slightly depending on the source, but this value is representative of mid-2015).
Price on June 17, 2025:
By June 2025, the Eli Lilly stock is trading at about $900–$950 per share (depending on daily fluctuations; the average one-year price target, according to analysts, is around $990).
Calculation of Capital Gains
- Investment: $80 per share in 2015
- Current Value: $900–$950 per share in 2025
- Capital Gain excluding Dividends:
Gain = ((Current Price – Price then) / Price then) * 100%
Gain = ((925 – 80) / 80) * 100% ≈ +1056%
This means: An investment of $10,000 would be worth over $110,000 today – solely due to the price increase.
Including Dividends
Eli Lilly regularly pays dividends, currently yielding about 0.7% per annum. Over ten years, these payouts summed to several percentage points in addition to the capital gain.
Supposing an average annual dividend of around 2% was paid over the period, this roughly equals:
- Total Dividend over Ten Years ≈ $10,000 * (~20%)
That’s an additional approximately $2,000 in dividend payments on a $10,000 investment.
Total Return
- Capital Return: approx. +1056%
- Total Dividend Return: approx. +20% (conservatively estimated)
- Total Return including Reinvestment Effect: A bit higher, as reinvested dividends can generate further growth.
Thus, the actual total return of a long-term investment in Eli Lilly significantly exceeds the pure price increase and can be even higher depending on dividend reinvestment.
Conclusion
An investment in Eli Lilly stock ten years ago would have yielded substantial wealth growth – both through massive price increases and regular dividend payouts. This performance ranks among the best of major pharmaceutical companies worldwide and impressively demonstrates the potential of long-term investments in strong industry leaders with innovative products.